GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cellect Biotechnology Ltd (NAS:APOP) » Definitions » Purchase Of Business

Cellect Biotechnology (Cellect Biotechnology) Purchase Of Business : $0.00 Mil (TTM As of Jun. 2021)


View and export this data going back to 2016. Start your Free Trial

What is Cellect Biotechnology Purchase Of Business?

Cellect Biotechnology's purchase of business for the three months ended in Jun. 2021 was $0.00 Mil. It means Cellect Biotechnology spent $0.00 Mil on purchasing business. Cellect Biotechnology's purchase of business for the trailing twelve months (TTM) ended in Jun. 2021 was $0.00 Mil.

Compared with last quarter ($0.00 Mil in Dec. 2020 ), Cellect Biotechnology spent the same money on purchasing business in Jun. 2021 ($0.00 Mil).


Cellect Biotechnology Purchase Of Business Historical Data

The historical data trend for Cellect Biotechnology's Purchase Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cellect Biotechnology Purchase Of Business Chart

Cellect Biotechnology Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Purchase Of Business
Get a 7-Day Free Trial - - - - -

Cellect Biotechnology Quarterly Data
Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Jun21
Purchase Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Cellect Biotechnology Purchase Of Business Calculation

The amount used to purchase business.

Purchase Of Business for the trailing twelve months (TTM) ended in Jun. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cellect Biotechnology Purchase Of Business Related Terms

Thank you for viewing the detailed overview of Cellect Biotechnology's Purchase Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.


Cellect Biotechnology (Cellect Biotechnology) Business Description

Traded in Other Exchanges
N/A
Address
23 Hata’as Street, Kfar Saba, ISR, 44425
Cellect Biotechnology Ltd is a biotechnology company that has developed a novel technology platform known as ApoGraft that functionally selects cells in order to improve the safety and efficacy of regenerative medicine and cell therapies. The company is developing its first product based on its ApoGraft technology platform, the ApoTainer kit that utilizes FasL- apoptotic protein.

Cellect Biotechnology (Cellect Biotechnology) Headlines

From GuruFocus

Cellect Biotechnology Receives Approval for U.S. Clinical Trial

By PRNewswire PRNewswire 12-23-2019

Cellect Biotechnology Initiates U.S. Clinical Trial of ApoGraft

By Marketwired Marketwired 10-22-2020